As of 2024-07-27, the EV/EBITDA ratio of Arena Pharmaceuticals Inc (ARNA) is -10.98. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ARNA's latest enterprise value is 5,982.02 mil USD. ARNA's TTM EBITDA according to its financial statements is -545.06 mil USD. Dividing these 2 quantities gives us the above ARNA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 16.6x - 25.7x | 20.1x |
| Forward P/E multiples | 20.1x - 25.2x | 23.7x |
| Fair Price | (174.70) - (219.96) | (190.62) |
| Upside | -274.7% - -320.0% | -290.6% |
| Date | EV/EBITDA |